PolyPid’s (PYPD) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research note issued to investors on Monday,Benzinga reports. They currently have a $14.00 price target on the stock. Separately, Craig Hallum assumed coverage on shares of PolyPid in a research note on Monday, November 4th. They issued a “buy” […]
More Stories
M&T Bank Completes $1.5 Billion Senior Notes Offering
On December 17, 2024, M&T Bank Corporation successfully closed a public offering, raising a total of $1.5 billion through the...
Tripadvisor (NASDAQ: TRIP) Announces Agreement with Liberty TripAdvisor Holdings, Inc. Regarding Merger
Tripadvisor, Inc. has disclosed a significant agreement with Liberty TripAdvisor Holdings, Inc. in an 8-K filing submitted to the Securities...
Disc Medicine, Inc. (NASDAQ:IRON) CEO John D. Quisel Sells 12,791 Shares
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) CEO John D. Quisel sold 12,791 shares of the company’s stock in...
Guidewire Software, Inc. (NYSE:GWRE) President John P. Mullen Sells 7,165 Shares of Stock
Guidewire Software, Inc. (NYSE:GWRE – Get Free Report) President John P. Mullen sold 7,165 shares of the stock in a...
3D Systems Co. (NYSE:DDD) EVP Charles W. Hull Sells 115,971 Shares of Stock
3D Systems Co. (NYSE:DDD – Get Free Report) EVP Charles W. Hull sold 115,971 shares of the company’s stock in...
Playtika Holding Corp. (NASDAQ:PLTK) Major Shareholder Holding Uk Ltd Playtika II Sells 75,923 Shares of Stock
Playtika Holding Corp. (NASDAQ:PLTK – Get Free Report) major shareholder Holding Uk Ltd Playtika II sold 75,923 shares of the...